European Journal of Heart Failure

FEBRUARY 26, 2025

Proposed approach for clinical management and therapeutic optimization in patients with heart failure with reduced ejection fraction and low blood pressure. Low blood pressure with major or mild symptoms. **SBP SBP <80mmHg or symptomatic low BP or asymptomatic low BP.

Blood Pressure 58

Blood Pressure Heart Failure Aortic valve TAVR 58

DAIC

JUNE 11, 2024

Columbia University Irving Medical Center’s Division of Cardiology has announced its launch of the Mitral & Tricuspid Center. Kodali, MD, pictured here, is one of the members of its leadership team, and director of the Structural Heart and Valve Center at CUIMC/NewYork-Presbyterian Hospital.

Tricuspid 52

Tricuspid Bicuspid/Mitral Heart Valves Innovation 52

European Journal of Heart Failure

DECEMBER 11, 2024

Abstract Worldwide, valvular heart disease (VHD) is a common cause of hospitalization for acute heart failure. In acute heart failure caused by VHD, symptoms result from rapid haemodynamic changes and subsequent decline in cardiac function, and if left untreated, leads to acute decompensation and cardiogenic shock.

Cardiogenic Shock 68

Cardiogenic Shock Heart Disease Heart Failure Bicuspid/Mitral 68

DAIC

JANUARY 8, 2024

milla1cf Mon, 01/08/2024 - 14:35 January 8, 2024 — University Hospitals (UH) Harrington Heart & Vascular Institute recently became the first center in the world to implant Medtronic’s Penditure Left Atrial Appendage (LAA) Exclusion System through a minimally invasive approach during a mitral valve repair procedure.

Bicuspid/Mitral 124

Bicuspid/Mitral Atrial Fibrillation Anatomy Coronary Artery Disease 124

Circulation

NOVEMBER 11, 2024

All-cause hospitalization (HR: 2.31, 95%CI: 2.04 – 2.62, p&lt;0.001), heart failure hospitalization (HR: 2.22, 95%CI: 1.92 – 2.55, p&lt;0.001), acute myocardial infarction (HR: 2.06, 95%CI: 1.79 – 2.35, p&lt;0.001), unstable angina (HR: 2.28, 95%CI: 1.72-3.04, vs non-MAC (58.2 + 12.6).

Heart Failure 40

Heart Failure Preserved Ejection Fraction Bicuspid/Mitral Outcomes 40

Circulation: Cardiovascular Interventions

JANUARY 18, 2024

BACKGROUND:Limited data exist regarding the impact of mitral annular calcification (MAC) on outcomes of transcatheter edge-to-edge repair for mitral regurgitation (MR).METHODS:We Circulation: Cardiovascular Interventions, Ahead of Print. with functional MR) who underwent an isolated, first-time intervention. versus 9.6%;P=0.016;

Bicuspid/Mitral 40

Bicuspid/Mitral Outcomes Heart Failure Echocardiogram 40

European Journal of Heart Failure

FEBRUARY 19, 2025

Prognostic impact of severe tricuspid regurgitation (TR) in patients with atrial functional mitral regurgitation (AFMR). Abstract Aims Tricuspid regurgitation (TR) is often seen in patients with atrial functional mitral regurgitation (AFMR). The primary endpoint was a composite of heart failure hospitalization and all-cause mortality.

Tricuspid 40

Tricuspid Bicuspid/Mitral Atrial Fibrillation Heart Failure 40

DAIC

FEBRUARY 2, 2024

“Edwards has a long history of leading innovation and pioneering new therapies to address the unmet needs of patients with structural heart disease,” said Daveen Chopra , Edwards’ corporate vice president, transcatheter mitral and tricuspid therapies. “We

Tricuspid 100

Tricuspid Quality of Life Bicuspid/Mitral Innovation 100

DAIC

JANUARY 16, 2024

Dr. Shreenivas brings his rich experience in both the clinical and commercial aspects of the structural heart landscape to his new role with Cardiac Dimensions. He led the structural heart program and cardiac catheterization laboratory at the University of Cincinnati and spent several years with The Christ Hospital in Ohio.

Bicuspid/Mitral 59

Bicuspid/Mitral Heart Failure Catheterization Laboratory Innovation 59

DAIC

AUGUST 27, 2024

We know that structural heart disease and heart failure are the leading causes of hospitalization and morbidity in the U.S. 2 “We assessed the device’s performance for two key tasks: the calculation of eight cardiac measurements and the interpretation of four valvular pathologies,” said Dr.

Ultrasound 98

Ultrasound Tricuspid Bicuspid/Mitral Aortic 98

Journal of the American Heart Association

FEBRUARY 26, 2025

Journal of the American Heart Association, Ahead of Print.

Heart Failure 45

Heart Failure Bicuspid/Mitral Hospital 45

Circulation: Cardiovascular Imaging

MARCH 21, 2025

Severe mitral regurgitation (MR) also causes a low-flow state, adding complexity to diagnosis and management. BACKGROUND:Patients with paradoxical low-flow, low-gradient severe aortic stenosis exhibit low transvalvular flow rate (Q), while maintaining preserved left ventricular ejection fraction.

Stenosis 40

Stenosis Aortic Aortic valve Bicuspid/Mitral 40

NEJM Journal Watch - Cardiology

SEPTEMBER 3, 2024

Transcatheter repair was associated with less heart failure hospitalization than medical therapy alone in one randomized trial — and was noninferior to surgery in another trial.

Bicuspid/Mitral 40

Bicuspid/Mitral Heart Failure Hospital 40

Journal of the American Heart Association

FEBRUARY 23, 2024

Journal of the American Heart Association, Ahead of Print. We sought to examine the prognostic value of combining predischarge MR, TR, and TMPG to study long‐term outcomes after TEER.Methods and ResultsWe reviewed the records of 291 patients who underwent successful mitral TEER at our institution between March 2014 and June 2022.

Bicuspid/Mitral 40

Bicuspid/Mitral Outcomes Risk Factors Tricuspid 40

European Journal of Heart Failure

JANUARY 14, 2025

The International Registry of MitraClip in Acute Mitral Regurgitation following Acute Myocardial Infarction (IREMMI). Methods and results The International Registry of MitraClip in Acute Mitral Regurgitation following Acute Myocardial Infarction (IREMMI) includes 187 patients with severe MR post-MI managed with TEER.

Myocardial Infarction 40

Myocardial Infarction Bicuspid/Mitral Cardiogenic Shock Risk Factors 40

Circulation: Cardiovascular Imaging

FEBRUARY 28, 2024

BACKGROUND:Patients with only moderate atrial secondary mitral regurgitation (asMR) frequently develop heart failure (HF). Although mild/moderate primary mitral regurgitation is compensated by left ventricular (LV) dilatation, the LV is not dilated in asMR. Circulation: Cardiovascular Imaging, Ahead of Print.

Atrial Fibrillation 40

Atrial Fibrillation Bicuspid/Mitral Pulmonary Cardiovascular Imaging 40

DAIC

AUGUST 29, 2024

“Comprehensive echocardiographic exam with a 5G cellular network and robotic arm-based remote system is feasible with relatively good diagnostic accuracy,” said study author Dr Yu Liu, Zhongshan Hospital, Shanghai, China. However, this expertise is often limited or unavailable in rural or indeed smaller urban areas.

Echocardiogram 52

Echocardiogram Bicuspid/Mitral Aortic valve Outpatient 52

Heart BMJ

MARCH 12, 2024

Following hospital admission, the patient underwent a bone marrow biopsy which was consistent with acute promyelocytic leukemia (APL) and her course was complicated by multiple embolic strokes and right-sided heart failure requiring inotropic support.

Bicuspid/Mitral 40

Bicuspid/Mitral Embolism Pulmonary Heart Failure 40

DAIC

FEBRUARY 18, 2025

Patients with aortic/mitral/tricuspid valve disease or root/ascending aorta >40 mm were included as soon as they were diagnosed with heart valve disease.

Heart Valves 52

Heart Valves Quality of Life Cardiothoracic Outcomes 52

EMS 12-Lead

MAY 20, 2022

Additional architectural changes include systolic anterior motion of the mitral valve, endothelial dysfunction at the level of the coronary arterial bed, and ventricular diastolic dysfunction. This worried the crew of potential acute coronary syndrome and STEMI was activated pre-hospital.

Cardiomyopathy 52

Cardiomyopathy Ischemia STEMI Coronary Angiogram 52

Journal of the American Heart Association

MARCH 7, 2025

BackgroundPatients with severe mitral regurgitation and cardiogenic shock demonstrate a poor prognosis. The primary outcome was device success and allcause death, while secondary outcomes included myocardial infarction, stroke, and heart failure hospitalization rates at 30day and intermediateterm followup.

Cardiogenic Shock 45

Cardiogenic Shock Bicuspid/Mitral Myocardial Infarction Heart Failure 45

Journal of the American Heart Association

DECEMBER 24, 2024

Journal of the American Heart Association, Ahead of Print. DAH was calculated as the number of days alive and spent outside a hospital, skilled nursing facility, inpatient rehabilitation, longterm acute care hospital, emergency department, or observation stay after randomization.

Bicuspid/Mitral 45

Bicuspid/Mitral Heart Failure Medicare Inpatient 45

Medical Xpress - Cardiology

SEPTEMBER 3, 2024

Mitral transcatheter edge-to-edge repair (M-TEER) reduced cardiovascular death and heart failure (HF)-related hospitalizations with improved health status in patients with HF and moderate to severe functional mitral regurgitation (FMR), according to late-breaking research presented in a Hot Line session today at ESC Congress 2024.

Bicuspid/Mitral 52

Bicuspid/Mitral Heart Failure Hospital Research 52

Nature Reviews - Cardiology

SEPTEMBER 18, 2024

Nature Reviews Cardiology, Published online: 19 September 2024; doi:10.1038/s41569-024-01089-9 In patients with heart failure and secondary mitral valve regurgitation, transcatheter edge-to-edge repair is non-inferior to mitral valve surgery with respect to a composite of death, hospitalization for heart failure, reintervention, implantation of an (..)

Bicuspid/Mitral 52

Bicuspid/Mitral Heart Failure Hospital Strokes 52

American College of Cardiology

AUGUST 31, 2024

Patients with recent HF hospitalizations prior to undergoing M-TEER saw even greater benefits, according to a sub-analysis published in JACC.

Bicuspid/Mitral 54

Bicuspid/Mitral Heart Failure Hospital Article 54

DAIC

APRIL 9, 2024

UC Davis Medical Center is one of the first sites nationwide to have commercial access to TriClip and is the first hospital in Western United States to utilize the system since it was approved by the U.S. Left untreated, tricuspid regurgitation can lead to atrial fibrillation , heart failure , kidney disease and even death.

Tricuspid 111

Tricuspid Heart Valves Bicuspid/Mitral Quality of Life 111

Circulation

NOVEMBER 11, 2024

Background:Sex differences in physiology and presentation have been well established across the heart failure (HF) spectrum. Women had a worse Minnesota Living with Heart Failure physical subscore (34.6±5 p=0.008) and more physical signs of congestion (10.7±2.3 On PAC, right atrial pressure (11.1±5.8

Heart Failure 40

Heart Failure Biomarkers Pulmonary Bicuspid/Mitral 40

Dr. Smith's ECG Blog

MARCH 6, 2020

NT-proBNP values less than 300 pg/ml have a 99% negative predictive value for excluding congestive heart failure. A cutoff of 1200 pg/ml for patients with a normal eGFR is very specific for heart failure. The patient was given furosemide and admitted to the hospital. Mild to moderate mitral regurgitation.

Heart Failure 52

Heart Failure Tachycardia Atrial Flutter Cardiomyopathy 52

International Journal of Cardiovascular Sciences

OCTOBER 21, 2024

Award Winners: Arquivos Brasileiros de Cardiologia Best Original Article – Determining Percentiles of Atherosclerotic Cardiovascular Risk According to Sex and Age in a Healthy Brazilian Population Authors: Fernando Yue Cesena, Nea Miwa Kashiwagi, Carlos Andre Minanni, Raul D.

Article 52

Article Preserved Ejection Fraction COVID-19 Heart Failure 52

DAIC

APRIL 2, 2024

Headrick Family Chair of the Valve Science Center for the Minneapolis Heart Institute Foundation , director of the Center for Valve and Structural Heart Disease for the Minneapolis Heart Institute at Abbott Northwestern Hospital, and co-principal investigator of the TRILUMINATE Pivotal trial.

Tricuspid 105

Tricuspid Heart Valves Quality of Life Open-Heart Surgery 105

Cardiometabolic Health Congress

SEPTEMBER 13, 2024

Mitral Valve Assessment Workshop: Corrado Fiore, MD (Italy), led a GE Healthcare-sponsored workshop on mitral valve assessment, featuring live echocardiogram scanning and hands-on sessions that guided participants from anatomical understanding to full diagnosis. FINEARTS Trial: Prof. Young Investigator Award on Imaging: Drs.

Hypertension 59

Hypertension Cardiovascular Disease Bicuspid/Mitral Arrhythmia 59

Circulation

NOVEMBER 11, 2024

Methodology:The HFrEF patients’ data were prospectively evaluated during the initial assessment and those hospitalized, and subseguently followed for at least 12months. Sex, age and racial/ethnic disparities, in-hospital management, follow-ups, health status and 1year mortality were assessed.

Biomarkers 40

Biomarkers Heart Failure Risk Factors Atrial Fibrillation 40

Society of Thoracic Surgeons - Research

APRIL 20, 2023

Adult Cardiac Surgery Database Lead Author Title Publication Date Jacob Raphael Red Blood Cell Transfusion and Pulmonary Complications: The Society of Thoracic Surgeons Adult Cardiac Surgery Database Analysis The Annals of Thoracic Surgery January 2024 Joseph Sabik Multi-Arterial versus Single-Arterial Coronary Surgery: Ten Year Follow-up of One Million (..)

Research 52

Research Coronary Artery Bypass Graft Aortic valve Congenital 52

Society of Thoracic Surgeons - Research

APRIL 20, 2023

Program Designations Access and Publications (A&P) 1 Participant User File (PUF) 2 Task Force on Funded Research (TFR) 3 Special Projects 4 Adult Cardiac Surgery Database Lead Author Title Publication Date William Keeling 2 National Trends in Emergency Coronary Artery Bypass Grafting European Journal of Cardiothoracic Surgery October 2023 Jake (..)

Research 52

Research Coronary Artery Bypass Graft Aortic valve Congenital 52

European Journal of Heart Failure

JANUARY 8, 2025

Abstract Aims Secondary mitral regurgitation (SMR) and tricuspid regurgitation (TR) are the most common valvular heart diseases in patients with heart failure (HF).

Heart Failure 76

Heart Failure Bicuspid/Mitral Tricuspid Document 76

Frontiers in Cardiovascular Medicine

JANUARY 9, 2025

ObjectiveThis meta-analysis aims to assess the impact of pulmonary hypertension (PH) on the clinical prognosis of patients with moderate to severe mitral valve regurgitation (MR) undergoing transcatheter edge-to-edge mitral valve repair (TEER).MethodsAs

Bicuspid/Mitral 52

Bicuspid/Mitral Pulmonary Hypertension Heart Failure 52

Dr. Smith's ECG Blog

MARCH 3, 2025

Anything that causes pulmonary edema: poor LV function, fluid overload, previous heart failure (HFrEF or HFpEF), valvular disease. Cardiology services were consulted at a PCI capable hospital. The scan showed a bicuspid aortic valve with severe stenosis and coronary artery disease. What other pathology is possible?

Tachycardia 73

Tachycardia Pulmonary Chest Pain Stenosis 73